Information;Judgment — ECLI:EU:T:2024:906
Date: 2024-12-18
Language of the case: German
Court formation: First Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: Germany

Action brought on 22 August 2023 – Hecht Pharma v EUIPO – Gufic BioSciences (H 15 Gufic H 15 Gufic) (Case T-520/23) Language in which the application was lodged: German Parties Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers) Defendant: European Union Intellectual Property Office Other party to the proceedings before the Board of Appeal: Gufic BioSciences Ltd. (Mumbai, India) Details of the proceedings before EUIPO Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal Trade mark at issue: EU figurative mark H 15 Gufic H 15 Gufic – EU trade mark No 8 285 661 Proceedings before EUIPO: Cancellation proceedings Contested decision: Decision of the Second Board of Appeal of EUIPO of 13 June 2023 in Case R 902/2021-2 Form of order sought The applicant claims that the Court should: annul the contested decision and declare the trade mark at issue to be revoked also in respect of Class 5 ‘Medicines’; order EUIPO to pay the costs of the appeal proceedings and of the pre-litigation procedure. Plea in law Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. ____________